New research identifies a critical genetic variation in Group 3 medulloblastomas, paving the way for improved diagnostic and treatment strategies for this challenging form of pediatric brain cancer
Transplant replaces dopaminergic neurons, which are degenerated in patients with Parkinson’s disease
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.